There has been little volume so far and there is going to be a lot more. Much of that will be the shorters racing to cover.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025